Faecal calprotectin as an aid to the diagnosis of non-IgE mediated cow's milk protein allergy
Copyright © 2015 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved..
INTRODUCTION: The aim of the study was to assess the use of faecal calprotectin (FCP) in infants with signs and symptoms of non-IgE-mediated cow's milk protein allergy (CMA) for both diagnosis and prediction of clinical response at the time of withdrawal of milk proteins.
PATIENTS AND METHODS: A one year prospective study was conducted on 82 infants between 1 and 12 months of age in the Eastern area of Málaga-Axarquía, of whom 40 of them had been diagnosed with non-IgE-mediated CMA (with suggestive symptoms and positive response to milk withdrawal), 12 not diagnosed with CMA, and 30 of them were the control group. FCP was measured at three different times: time of diagnosis, and one and three months later. ANOVA for repeated measures, nominal logistic regression and ROC curves were prepared using the SPSS.20 package and Medcalc.
RESULTS: Differences between diagnostic and control groups were assessed: there was a statistically significant relationship (p<.0001) between high FCP levels and infants suffering CMA, as well as the levels at time of diagnosis, 1 and 3 months (p <.001). A ROC curve was constructed between FCP levels and diagnosis of CMA, with 138 ug/g, with the best cut-off being with an area under the curve of 0.89. However, it is only 0.68 to predict a clinical response.
CONCLUSIONS: FCP levels lower than 138ug/g could be useful to rule out non-IgE-mediated CMA diagnosis. Calprotectin is not a good test to predict clinical response to milk withdrawal.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
|---|---|
| Enthalten in: |
Anales de pediatria (Barcelona, Spain : 2003) - 84(2016), 6 vom: 01. Juni, Seite 318-23 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Calprotectina fecal como apoyo al diagnóstico en la alergia a las proteínas de leche de vaca no IgE mediada |
|---|
| Beteiligte Personen: |
Trillo Belizón, Carlos [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
37341-29-0 |
|---|
| Anmerkungen: |
Date Completed 19.10.2017 Date Revised 19.10.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anpedi.2015.07.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM252484185 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM252484185 | ||
| 003 | DE-627 | ||
| 005 | 20231224164218.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.1016/j.anpedi.2015.07.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0841.xml |
| 035 | |a (DE-627)NLM252484185 | ||
| 035 | |a (NLM)26342278 | ||
| 035 | |a (PII)S1695-4033(15)00286-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Trillo Belizón, Carlos |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Faecal calprotectin as an aid to the diagnosis of non-IgE mediated cow's milk protein allergy |
| 246 | 3 | 3 | |a Calprotectina fecal como apoyo al diagnóstico en la alergia a las proteínas de leche de vaca no IgE mediada |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.10.2017 | ||
| 500 | |a Date Revised 19.10.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2015 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a INTRODUCTION: The aim of the study was to assess the use of faecal calprotectin (FCP) in infants with signs and symptoms of non-IgE-mediated cow's milk protein allergy (CMA) for both diagnosis and prediction of clinical response at the time of withdrawal of milk proteins | ||
| 520 | |a PATIENTS AND METHODS: A one year prospective study was conducted on 82 infants between 1 and 12 months of age in the Eastern area of Málaga-Axarquía, of whom 40 of them had been diagnosed with non-IgE-mediated CMA (with suggestive symptoms and positive response to milk withdrawal), 12 not diagnosed with CMA, and 30 of them were the control group. FCP was measured at three different times: time of diagnosis, and one and three months later. ANOVA for repeated measures, nominal logistic regression and ROC curves were prepared using the SPSS.20 package and Medcalc | ||
| 520 | |a RESULTS: Differences between diagnostic and control groups were assessed: there was a statistically significant relationship (p<.0001) between high FCP levels and infants suffering CMA, as well as the levels at time of diagnosis, 1 and 3 months (p <.001). A ROC curve was constructed between FCP levels and diagnosis of CMA, with 138 ug/g, with the best cut-off being with an area under the curve of 0.89. However, it is only 0.68 to predict a clinical response | ||
| 520 | |a CONCLUSIONS: FCP levels lower than 138ug/g could be useful to rule out non-IgE-mediated CMA diagnosis. Calprotectin is not a good test to predict clinical response to milk withdrawal | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Alergia a proteínas de leche de vaca | |
| 650 | 4 | |a Calprotectina fecal | |
| 650 | 4 | |a Cow's milk allergy | |
| 650 | 4 | |a Faecal calprotectin | |
| 650 | 4 | |a Immunoglobulin E | |
| 650 | 4 | |a Inmunoglobulina E | |
| 650 | 7 | |a Leukocyte L1 Antigen Complex |2 NLM | |
| 650 | 7 | |a Milk Proteins |2 NLM | |
| 650 | 7 | |a Immunoglobulin E |2 NLM | |
| 650 | 7 | |a 37341-29-0 |2 NLM | |
| 700 | 1 | |a Ortega Páez, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Medina Claros, Antonio F |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez Sánchez, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Reina González, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Vera Medialdea, Rafael |e verfasserin |4 aut | |
| 700 | 1 | |a Ramón Salguero, José Manuel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anales de pediatria (Barcelona, Spain : 2003) |d 2001 |g 84(2016), 6 vom: 01. Juni, Seite 318-23 |w (DE-627)NLM124027334 |x 1695-4033 |7 nnns |
| 773 | 1 | 8 | |g volume:84 |g year:2016 |g number:6 |g day:01 |g month:06 |g pages:318-23 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anpedi.2015.07.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 84 |j 2016 |e 6 |b 01 |c 06 |h 318-23 | ||